Lee's Pharmaceutical Holdings Limited (LPCUF)
USD 0.19
(0.0%)
USD 0.19
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.05 Billion | 157.85 Million | 162.35 Million | 156.91 Million | 156.43 Million | 145.3 Million |
| Cost of Revenue | 501.72 Million | 59.19 Million | 58.96 Million | 56.18 Million | 53.98 Million | 49.97 Million |
| Gross Profit | 551.31 Million | 98.66 Million | 103.38 Million | 100.73 Million | 102.44 Million | 95.32 Million |
| Operating Expenses | 590.99 Million | 91.33 Million | 127.95 Million | 93.13 Million | 82.24 Million | 72.88 Million |
| Selling, General and Administrative Expenses | 494.18 Million | 69.71 Million | 96.68 Million | 66.91 Million | 63 Million | 53.32 Million |
| Research and Development Expenses | 96.8 Million | 21.61 Million | 31.26 Million | 26.21 Million | 19.24 Million | 19.56 Million |
| Other Expenses | - | 52.06 Million | 78.25 Million | 69.34 Million | 57.31 Million | 21.24 Million |
| Cost and Expenses | 1.09 Billion | 150.52 Million | 186.92 Million | 149.31 Million | 136.23 Million | 122.86 Million |
| Operating Income | 36.04 Million | 7.32 Million | -24.56 Million | 7.59 Million | 20.19 Million | 22.44 Million |
| Interest Expense | 11.89 Million | 972.23 Thousand | 733.73 Thousand | 834.68 Thousand | 850.12 Thousand | 4.16 Million |
| Income Tax Expense | 10.83 Million | 2.81 Million | 1.21 Million | 7.15 Million | 7.64 Million | 7.23 Million |
| Earnings before Tax | 30.78 Million | 8.82 Million | 252.97 Million | 18.75 Million | 17.29 Million | 57.01 Million |
| Net Income | 16.69 Million | 6.56 Million | 254.81 Million | 16.67 Million | 16.11 Million | 53.42 Million |
| Earnings Per Share Basic | 0.03 | 0.01 | 0.43 | 0.03 | 0.03 | 0.09 |
| Earnings Per Share Diluted | 0.03 | 0.01 | 0.43 | 0.03 | 0.03 | 0.09 |
| Weighted Average Shares Outstanding | 588.83 Million | 588.83 Million | 588.64 Million | 588.12 Million | 591.57 Million | 591.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 588.83 Million | 588.83 Million | 589.04 Million | 588.16 Million | 591.88 Million | 595.15 Million |
| Gross Margin | 0.52 | 0.63 | 0.64 | 0.64 | 0.65 | 0.66 |
| EBIT Margin | 0.10 | 0.17 | -0.04 | 0.15 | 0.21 | 0.21 |
| Profit Margin | 0.02 | 0.04 | 1.57 | 0.11 | 0.10 | 0.37 |
| EBITDA | 109.82 Million | 226.97 Million | 2.12 Billion | 266.92 Million | 222.78 Million | 518.65 Million |
| Earnings Before Tax Margin | 0.03 | 0.05 | -0.15 | 0.05 | 0.13 | 0.15 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 134.81 Million | 69.22 Million | 34.52 Million | 65.35 Million | 32.63 Million | 157.85 Million |
| Cost of Revenue | 64.23 Million | 35.06 Million | 17.48 Million | 29.06 Million | 14.51 Million | 59.19 Million |
| Gross Profit | 70.58 Million | 34.16 Million | 17.03 Million | 36.28 Million | 18.11 Million | 98.66 Million |
| Operating Expenses | 75.66 Million | 38.97 Million | 16.46 Million | 36.56 Million | 16.11 Million | 91.33 Million |
| Selling, General and Administrative Expenses | - | 32.82 Million | 16.36 Million | 30.33 Million | 15.14 Million | - |
| Research and Development Expenses | - | 6.14 Million | 5.71 Million | 6.22 Million | 3.1 Million | - |
| Other Expenses | 43.4 Million | - | - | - | - | 52.06 Million |
| Cost and Expenses | 139.9 Million | 74.03 Million | 33.94 Million | 65.62 Million | 30.62 Million | 150.52 Million |
| Operating Income | -5.08 Million | -4.8 Million | 232.22 Thousand | -273.76 Thousand | 2.06 Million | 7.32 Million |
| Interest Expense | 11.27 Million | 826.94 Thousand | - | 693.85 Thousand | - | 972.23 Thousand |
| Income Tax Expense | 1.38 Million | 583.43 Thousand | 290.96 Thousand | 801.01 Thousand | 399.93 Thousand | 2.81 Million |
| Earnings before Tax | 4.05 Million | 515.57 Thousand | 229.67 Thousand | 3.52 Million | 1.73 Million | 8.82 Million |
| Net Income | 2.13 Million | 74.38 Thousand | 37.09 Thousand | 2.05 Million | 1.02 Million | 6.56 Million |
| Earnings Per Share Basic | - | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Earnings Per Share Diluted | - | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Weighted Average Shares Outstanding | 588.83 Million | 588.83 Million | 589.24 Million | 588.83 Million | 588.85 Million | 588.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 588.83 Million | 588.83 Million | 588.83 Million | 588.83 Million | 588.83 Million | 588.83 Million |
| Gross Margin | 0.52 | 0.49 | 0.49 | 0.56 | 0.56 | 0.63 |
| EBIT Margin | - | 0.06 | 0.04 | 0.15 | 0.22 | - |
| Profit Margin | 0.02 | 0.00 | 0.00 | 0.03 | 0.03 | 0.04 |
| EBITDA | - | 4.38 Million | 1.3 Million | 9.64 Million | 7.01 Million | - |
| Earnings Before Tax Margin | -0.04 | -0.07 | 0.01 | -0.00 | 0.06 | 0.05 |
1480
STC
HXPLF
IRON
SLTFF
APCXW